FDA Lilly - Search News

News

Eli Lilly Vows to Make Weight-Loss Pill in U.S.

CBS News on MSN · 20h

Eli Lilly says GLP-1 pill for diabetes and weight loss effective in study, plans to seek FDA approval

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for diabetes and weight loss.

Investopedia on MSN · 1d

Eli Lilly Stock Soars on Oral Weight-Loss Drug Trial Results

Key Takeaways Shares of Eli Lilly jumped 16% Thursday morning after the pharmaceutical company released Phase 3 trial results for its oral weight-loss drug that "demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines.

UPI on MSN · 1d

Experimental Eli Lilly weight loss drug proves promising for type 2 diabetics

People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its latest clinical testing, the Indianapolis-based drugmaker announced Thursday.

A very good day for Lilly, and a bad day for Novo

In a new First Opinion essay, Borio and Krause, both once top FDA officials, say the commissioner made a “rookie misstep” in ...

Fierce Biotech1d

Lilly's oral GLP-1 drug delivers Ozempic-like efficacy in phase 3 diabetes trial

Eli Lilly has met its goal of achieving semaglutide-like efficacy with an oral GLP-1 drug. | Eli Lilly has met its goal of ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results